Keywords: مپولیزومب; Severe eosinophilic asthma; Exacerbations; IL-5; Mepolizumab;
مقالات ISI مپولیزومب (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مپولیزومب; Asthma; Mepolizumab; Placebo; Safety; Treatment efficacy; ACQ; Asthma Control Questionnaire; AE; adverse event; CI; confidence interval; ED; emergency department; FEV1; forced expiratory volume in 1Â second; FVC; forced vital capacity; GINA; Global Initia
Keywords: مپولیزومب; Mepolizumab; Omalizumab; Severe asthma; Exacerbations; Lung function; Tolerability; Crl; credible interval; HRQoL; health related quality of life; ITC; indirect treatment comparison; MEPO; mepolizumab; OCS; oral corticosteroid; OMA; omalizumab; RCT; rando
Keywords: مپولیزومب; Anti-drug antibodies (ADA); Immunogenicity; IL-5; Mepolizumab;
Keywords: مپولیزومب; Antiasthmatic agents; exacerbation; emergency service; hospital; IL-5; mepolizumab; severe eosinophilic asthma; meta-analysis; IV; Intravenous; OCS; Oral corticosteroid; SC; Subcutaneous;
Keywords: مپولیزومب; Severe asthma; Mepolizumab; Pharmacogenetics; Exacerbation;
Keywords: مپولیزومب; Nasal polyposis; mepolizumab; IL-5; eosinophil; chronic rhinosinusitis; AE; Adverse event; ECG; Electrocardiography; EQ-5D; EuroQual 5-Dimensions; FVC; Forced vital capacity; ITT; Intent-to-treat; PEFR; Peak expiratory flow rate; PK; Pharmacokinetics; PnI
Keywords: مپولیزومب; Bronchial thermoplasty; difficult-to-control asthma; exacerbations; mepolizumab; omalizumab; phenotypes; severe asthma
Keywords: مپولیزومب; Asthma; childhood asthma; dupilumab; inhaled corticosteroids; lebrikizumab; nitric oxide; mepolizumab; omalizumab; severe asthma;
Keywords: مپولیزومب; Asthma; Early asthma; Inhaled corticosteroids; Lebrikizumab; Mepolizumab; Omalizumab; Severe asthma; Tiotropium;
Keywords: مپولیزومب; Asthma; asthma control; asthma exacerbations; dupilumab; biomarkers; inhaled corticosteroids; lebrikizumab; long-acting Ã-adrenergic agonists; mepolizumab; omalizumab; reslizumab; severe asthma; therapeutics; ACQ; Asthma control questionnaire; BADGER; Be
Development of a robust reporter gene based assay for the bioactivity determination of IL-5-targeted therapeutic antibodies
Keywords: مپولیزومب; Anti-IL-5 pharmaceuticals; Mepolizumab; Bioassay; Anti-proliferation assay; Reporter gene assay;
Perspectives de traitement par biomédicaments dans la granulomatose éosinophilique avec polyangéite (Churg-Strauss)
Keywords: مپولیزومب; Médicaments biologiques; Biomédicaments; Vascularite associée aux ANCA; Granulomatose éosinophilique avec polyangéite; Rituximab; Mépolizumab; Biological response modifiers; Biologics; ANCA-associated vasculitis; Eosinophilic granulomatosis with pol
Traitement par anti-IL-5 dans l'asthme sévère : vers la guerre des mabs ?
Keywords: مپولیزومب; Asthme; Ãosinophile; IL-5; Biothérapies; Benralizumab; Mépolizumab; Reslizumab; Asthma; Eosinophil; IL-5; Biotherapies; Benralizumab; Mépolizumab; Reslizumab;
Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study
Keywords: مپولیزومب; durability; exacerbations; mepolizumab; severe eosinophilic asthma; safety;
Biologic Therapies Targeting Eosinophils: Current Status and Future Prospects
Keywords: مپولیزومب; Hypereosinophilic syndrome; Eosinophilic gastrointestinal disorders; Asthma; mAb; Mepolizumab; Reslizumab; Benralizumab; EAD; Eosinophil-associated disease; EGPA; Eosinophilic granulomatosis with polyangiitis; EMR1; Human epidermal growth factor (EGF)-l
Novel targeted therapies for eosinophilic disorders
Keywords: مپولیزومب; Hypereosinophilic syndromes; eosinophil-associated gastrointestinal disorders; eosinophilic esophagitis; Churg-Strauss syndrome; IL-5; mepolizumab; reslizumabAD, Atopic dermatitis; ADCC, Antibody-dependent cell-mediated cytotoxicity; βc, Common β chain; C
Eosinophils, bronchitis and asthma: Pathogenesis of cough and airflow obstruction
Keywords: مپولیزومب; Eosinophils; Asthma; Eosinophilic bronchitis; Lung function; Airflow obstruction; Remodeling; Mepolizumab
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis
Keywords: مپولیزومب; Anti-IL-5; mepolizumab; eosinophils; chronic rhinosinusitis; nasal polyposis; AC; Available case analysis; AUC; Area under the curve; CFB; Change from baseline; CRSsNP; Chronic rhinosinusitis without nasal polyps; CRSwNP; Chronic rhinosinusitis with nas
Syndromes hyperéosinophiliques : actualités physiopathologiques et thérapeutiques
Keywords: مپولیزومب; Syndrome hyperéosinophilique; Physiopathologie; Imatinib; MepolizumabHypereosinophilic syndrome; Pathogeny; Imatinib; Mepolizumab
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome
Keywords: مپولیزومب; CD3-CD4+; lymphocytic variant HES; clonal T-cell; TARC; IL-5; mepolizumab; AITL; Angioimmunoblastic T-cell lymphoma; APC; Allophycocyanin; FITC; Fluorescein isothiocyanate; F/P; FIP1-like 1/platelet-derived growth factor receptor α fusion; HES; Hypereosi
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels
Keywords: مپولیزومب; Anti-IL-5; cytokines; eosinophilia; esophagitis; hypereosinophilic; IL-5; inflammation; mepolizumab; APC; Allophycocyanin; EE; Eosinophilic esophagitis; EGID; Eosinophilic-associated gastrointestinal disorders; FIP1L1-PDGFRA; FIP1L1-platelet-derived g
Hypereosinophilic syndromes
Keywords: مپولیزومب; Churg-Strauss syndrome; eosinophilia; hypereosinophilic syndrome; mepolizumab; physiopathology; treatment; tyrosine kinase
Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis
Keywords: مپولیزومب; Anti-IL-5; cytokine; eosinophils; eosinophilia; esophagitis; eotaxin-3; mepolizumab; IL-5; EE; Eosinophilic esophagitis; EGID; Eosinophilic gastrointestinal disorder; GERD; Gastroesophageal reflux disease; hpf; High-power field;
Anti-IL-5 and hypereosinophilic syndromes
Keywords: مپولیزومب; Anti-IL-5; Anti-interleukin-5; Eosinophilia; Hypereosinophilic syndromes; IL-5; Interleukin-5; Mepolizumab;